Tianjin Smith Kline & French Laboratories To Accelerate Drug Innovation In China
This article was originally published in PharmAsia News
Executive Summary
Tianjin Smith Kline & French Laboratories will establish an innovative center in Beijing focusing on drugs complying with international standards